Greetings and welcome to the Hillenbrand first quarter and full year 2025 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...

Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a specialty finance company with a market capitalization of $1.17 billion and trading near its 52-week high of $18.35, announced the issuance of $350 ...

Guidance to Reflect Transaction; Maintains Outlook for Remaining Businesses BATESVILLE, Ind., Feb. 5, 2025 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

(Batesville, IN) – Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital.

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Hillenbrand anticipates Q2 revenue in the range of $685 million to $705 million and adjusted EPS between $0.53 and $0.58. Full-year guidance has been updated to reflect the Milacron transaction, ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Highlights,Hillenbrand's Q1 revenue of $707 million decreased 9% year-over-year, in line with expectations.,The company is ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China. The company disclosed preliminary results in mid January, but it left out important ...